Pelthos Therapeutics Inc.

PTHS · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 92 employees
55
SEC Filings
$26.47
Close 2026-05-29
92
Employees

Business Summary

PART I Overview Pelthos Therapeutics Inc. (the Company) is a bio-pharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMI TM , XEPI , and XEGLYZE . The July 1, 2025 merger transaction between Channel Therapeutics Corporation ...

Latest Stock Quote

PTHS 2026-05-29 $26.47 O:$26.05 H:$27.1 L:$25.8001 Vol:0.0M VWAP:$26.7383
origin leaf: 43a3a6dc2d2d458350b18e890f391bfeae207909cd33199841c5fbdc9e2242ee

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001919246-26-000013EDGAR113K words
2025-03-272024-12-310001753926-25-000503EDGAR—
2024-04-162023-12-310001753926-24-000740EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001753926-25-001764EDGAR51K words
2025-08-132025-06-300001753926-25-001326EDGAR—
2025-05-132025-03-310001753926-25-000790EDGAR—
2024-11-132024-09-300001753926-24-001883EDGAR—
2024-08-132024-06-300001753926-24-001423EDGAR—
2024-05-152024-03-310001753926-24-000976EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001919246-26-000014EDGAR4K words
2026-01-130001753926-26-000097EDGAR—
2026-01-120001753926-26-000094EDGAR—
2026-01-020001753926-26-000010EDGAR—
2025-12-230001753926-25-001964EDGAR—
2025-12-170001753926-25-001906EDGAR—
2025-11-130001753926-25-001766EDGAR—
2025-11-070001753926-25-001715EDGAR—
2025-10-140001753926-25-001606EDGAR—
2025-09-030001753926-25-001425EDGAR—

55 total filings indexed. 36 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001919246
TickerPTHS
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV
Websitehttps://www.pelthos.com
Listed2024-02-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 50ee7bae8f42a86e1821b5193dda83f91949405f6c2bb1facb926d1ff4a4ca02
parent: 40a602a9d21a1dba653af7dabdde73a68b38c76b4287ebb57f5a175d2435628a
content hash: b660cf544a5fc61ac2a5e6eb4b47d26fab9335ccfce89f359d38552c6235dff5
signed: 2026-06-03T12:02:19.947Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf